More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$36.46B
EPS
4.73
P/E ratio
15.1
Price to sales
1.4
Dividend yield
0.198%
Beta
0.76761
Previous close
$81.89
Today's open
$82.50
Day's range
$80.29 - $83.07
52 week range
$58.75 - $89.77
show more
CEO
Peter J. Arduini
Employees
54000
Headquarters
Chicago, IL
Exchange
Nasdaq Global Select
Shares outstanding
452137831
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
GEHC Advances Manganese-Based MRI Agent to Phase 3 After Positive Data
GE HealthCare advances manganese-based MRI agent to Phase 3 after positive trial data, potentially expanding its imaging portfolio and addressing gadolinium-related concerns.
Zacks Investment Research • 19 hours ago

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced two new capabilities for Imaging 360, AI assistant and AI-assisted protocoling. The Imaging 360 AI assistant and AI-assist protocoling are designed to help imaging teams quickly find answers to protocol-related questions and support protocoling for CT and MR exams. Radiology departments manage complex workflows across sites, systems and care teams. Finding protocol information and analyzing the data can be time consuming. Se.
Business Wire • a day ago

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities
CHICAGO--(BUSINESS WIRE)--The GE HealthCare Foundation today announced its 2026 cohort of grant recipients, supporting organizations whose work will help expand access to lifesaving care for mothers and children around the world. This year's grantees are focused on building sustainable, technology-enabled healthcare infrastructure, equipping frontline healthcare workers with point-of-care diagnostics and advanced surgical training. Spanning three continents, these investments reflect the Founda.
Business Wire • 17 hours ago

Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Zacks Investment Research • Nov 19, 2026

GE HealthCare Wins FDA Nod for AI Feeding Tube Detection Software
GEHC secures FDA clearance for AI-powered feeding tube detection software, expanding bedside X-ray capabilities for adult and pediatric patients.
Zacks Investment Research • Nov 19, 2026

GE HealthCare's Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based magnetic resonance imaging (MRI) contrast agent (MBCA). If approved, MBCAs could offer an alternative to – or even replace – gadolinium-based contrast agents (GBCAs), the current standard of care. This is.
Business Wire • Nov 19, 2026

GE HealthCare Expands Global Research Network for Photon-Counting CT
GEHC expands its global research network for Photonova Spectra to advance photon-counting CT applications, clinical adoption and diagnostic capabilities.
Zacks Investment Research • Nov 18, 2026

GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the integration of the AW ONE ecosystem, a unified ecosystem for post processing and advanced visualization, with InteleViewer, IntelePACS' diagnostic viewer designed to support seamless radiology workflows.1 Clinicians can now launch advanced visualization and workflow automation applications in the AW ONE ecosystem directly within InteleViewer as they review and interpret images, without having to switch to a separate environmen.
Business Wire • Nov 18, 2026

Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks.
Zacks Investment Research • Nov 17, 2026

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals and research institutions across North America, Europe and Asia are beginning structured evaluations of Photonova Spectra to further define its clinical utility, optimize imaging protocols and explore n.
Business Wire • Nov 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell GE HealthCare Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.